The McKnight Brain Institute’s signature programs in neurological diseases include brain cancer and a range of neurodegenerative disorders including ALS, Alzheimer’s disease and Parkinson’s disease. The MBI is dedicated to accelerating discoveries in these fields to enhance brain health and develop innovative therapies.
1Florida Alzheimer’s Disease Research Center (1Florida ADRC)
The 1Florida ADRC is a UF-led consortium of five Florida institutions involving over 30 faculty members that evaluates people with and without memory disorders and other thinking problems for diagnosis and participation in research studies.
Learn more about the 1Florida ADRC.
Center for NeuroGenetics (CNG)
The CNG integrates molecular, genetic, and clinical approaches to find the causes of neurodegenerative disease and develop effective treatment strategies.
Center for Translational Research in Neurodegenerative Disease (CTRND)
The CTRND is an innovative, multidisciplinary research center focused on the discovery, development, and evaluation of future treatments and diagnostics for degenerative central nervous system conditions.
Preston A. Wells, Jr. Center for Brain Tumor Therapy
This center serves as a hub for some of the brightest minds in the fields of neuro-oncology, neurosurgery, and radiation oncology where leading researchers and their teams collaborate with physicians who have dedicated their entire careers to finding a cure for brain cancer.
Learn more about the Preston A. Wells, Jr. Center for Brain Tumor Therapy.
Recent News
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer’s patients using Glucosamine.
An analysis by MBI researchers shows that glucosamine use is associated with a 25% increase in progression from mild cognitive impairment to dementia.
Dr. Kimberly Alonge’s research explores the role of the brain’s extracellular matrices in neuro disorders as well as in aging, obesity and diabetes.
